Ventas, Inc. (VTR) News
Filter VTR News Items
VTR News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
VTR News Highlights
- For VTR, its 30 day story count is now at 27.
- Over the past 26 days, the trend for VTR's stories per day has been choppy and unclear. It has oscillated between 1 and 8.
- The most mentioned tickers in articles about VTR are NOV.
Latest VTR News From Around the Web
Below are the latest news stories about VENTAS INC that investors may wish to consider to help them evaluate VTR as an investment opportunity.
Ventas - Consensus Indicates Potential 5.1% Upside - DirectorsTalk InterviewsVentas - Consensus Indicates Potential 5.1% Upside |
Ventas Appoints J. Justin Hutchens, Executive Vice President, Senior Housing, to Additional Role of Chief Investment OfficerCHICAGO, January 23, 2023--Ventas, Inc. (NYSE: VTR) ("Ventas" or the "Company") today announced that J. Justin Hutchens, Executive Vice President, Senior Housing, has been appointed to the additional role of Chief Investment Officer, effective immediately. In his expanded role, Hutchens will be responsible for Ventas’s capital allocation strategy and execution across the enterprise in addition to his current responsibility for the Company’s Senior Housing portfolio. He will oversee both the Seni |
Ventas Announces Fourth Quarter 2022 Earnings Release Date and Conference CallCHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) will issue its fourth quarter 2022 earnings release after the close of trading on the New York Stock Exchange on Thursday, February 9, 2023. A conference call to discuss those earnings will be held on Friday, February 10, 2023 at 10:00 a.m. Eastern Time (9:00 a.m. Central Time). The dial-in number for the conference call is (888) 330-3576 (or +1 (646) 960-0672 for international callers), and the participant passcode is 7655497. A live webcast c |
Ventas Announces Tax Treatment Of 2022 DistributionsVentas, Inc. (NYSE: VTR) (the “Company”) announced today the tax treatment of its 2022 distributions on the Company’s common stock. For income tax purposes, total taxable dividend income for 2022 was $1.80 per share. This includes the Company’s fourth quarter 2021 dividend of $0.45 per share, which was declared on December 7, 2021 and was paid on January 19, 2022. It excludes the Company’s |
Ventas Inc. stock falls Friday, underperforms marketShares of Ventas Inc. shed 1.55% to $48.99 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index… |
5 Must-Buy REITs for Your January Buy ListHere are five exceptional REITs to buy that happen to offer consistent growth and healthy passive income for long-term investors right now. |
Ventas Inc. REIT: Relief Rally Gains New StrengthWhile quite a few real estate investment trusts (REITs) are just now coming off of new lows, Ventas Inc. (NYSE: VTR ) is up to a three-month high. The company is focused mostly on healthcare and owns 1,200 properties nationwide totaling 24 million square feet of space. Its market capitalization is $19.11 billion, putting the company in the relatively large category for the sector. Chicago-based Ventas is a component of the Standard & Poor’s 500 and offers a diverse portfolio of real estate, including 817 senior housing communities, 330 medical office buildings and life science research and innovation centers, among other projects. Funds from operations, reported Nov. 3, came in at $0.76 with quarterly revenue of $1 billion and annual … Full story available on Benzinga.com |
Cadence and Ardent Health Services Launch Remote Care Management Program to Improve Care and Outcomes for Patients Outside of ClinicsNEW YORK, January 04, 2023--Cadence today announced a partnership with Ardent Health Services to implement a remote patient monitoring and responsive virtual care program across Ardent’s operations, which include 30 hospitals and 200 sites of care in six states. Cadence delivers personalized, consistent care and intervention as needed from home by collecting, analyzing, and responding to patients’ vitals daily as an extension of their care team. |
Is It Wise to Retain Ventas (VTR) Stock in Your Portfolio?A rise in healthcare spending by senior citizens, accretive investments in the R&I business and a solid balance sheet bode well for Ventas (VTR). Meanwhile, stiff competition and higher interest rates are woes. |
Ventas Inc. (NYSE: VTR) Stock: Can It Surge Further?In the last trading session, 0.94 million shares of the Ventas Inc. (NYSE:VTR) were traded, and its beta was 1.17. Most recently the company’s share price was $45.49, and it changed around $0.23 or 0.51% from the last close, which brings the market valuation of the company to $18.09B. VTR currently trades at a discount … Ventas Inc. (NYSE: VTR) Stock: Can It Surge Further? Read More » |